$0.00030
0.000.00%
At close: -
$0.1000
0.133233.33%
After Hours: Feb 14, 8:34 AM EDT
Comments
Loading...
Scopus BioPharma (OTC:SCPS) Stock, Earnings Estimates, EPS, And Revenue
Scopus BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 21
EPS
$-0.090
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Scopus BioPharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Scopus BioPharma (SCPS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-21 | $-0.09 | $ | -10000.0 % |
| Jun 2022 | 2022-08-15 | $-0.16 | $ | -10000.0 % |
| Mar 2022 | 2022-05-19 | $-0.22 | $ | -10000.0 % |
| Mar 2022 | 2022-04-15 | $-0.33 | $ | -10000.0 % |
Scopus BioPharma (SCPS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Scopus BioPharma (OTCEM:SCPS) reporting earnings?
Scopus BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 21, 2022 for Q3.
What were the latest earnings per share (EPS) for Scopus BioPharma (OTCEM:SCPS)?
Scopus BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 21, 2022 for Q3 and the Actual EPS was $-0.09, which missed the estimate of $0.00.
What were Scopus BioPharma’s (OTCEM:SCPS) revenues?
Scopus BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 21, 2022 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.